Literature DB >> 31754815

Compound blue nevus: a reappraisal of the concept in the genomic era.

Julien Jaquemus1, Emilie Perron2, Adrien Buisson1, Gerardo Ferrara3, Veronique Haddad1, Arnaud de la Fouchardiere4,5.   

Abstract

We report a series of 21 compound blue nevi, a rare variant in the vast clinical and morphological spectrum of blue melanocytic proliferations. Clinically, they presented in young adults, with a slight female predominance. One-third were located on the dorsum of the foot. Morphologically, all cases displayed large dendritic melanocytes restricted to the deep layers of the epidermis. The compound component was central and evenly distributed. Melanocytic density ranged from scarce isolated cells to a confluent lentiginous architecture. In 12 of the 21 cases, junctional nests of small, bland, weakly pigmented melanocytes were associated. These nests became confluent in the most cellular cases. In all cases, a dermal component was immediately present underneath, mainly of cellular blue nevus-type. All cases were genetically confirmed to harbor either a GNAQ or GNA11 hotspot mutation. This study expands the morphological spectrum of blue nevi that should not be restricted to a strictly intradermal melanocytic proliferation.

Entities:  

Keywords:  Blue nevus; Compound blue nevus; GNA11; GNAQ; Kamino nevus

Mesh:

Substances:

Year:  2019        PMID: 31754815     DOI: 10.1007/s00428-019-02667-w

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  8 in total

Review 1.  Compound blue naevus: a potential simulator of melanoma.

Authors:  C Carrera; B Ferrer; J M Mascaró; J Palou
Journal:  Br J Dermatol       Date:  2006-07       Impact factor: 9.302

Review 2.  Blue Nevi and Related Tumors.

Authors:  Artur Zembowicz
Journal:  Clin Lab Med       Date:  2017-07-04       Impact factor: 1.935

3.  A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.

Authors:  Thomas Wiesner; Rajmohan Murali; Isabella Fried; Lorenzo Cerroni; Klaus Busam; Heinz Kutzner; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

4.  Cellular blue nevus. Clinicopathologic study of forty-five cases.

Authors:  H A Rodriguez; L V Ackerman
Journal:  Cancer       Date:  1968-03       Impact factor: 6.860

5.  Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes.

Authors:  Jarish N Cohen; Nancy M Joseph; Jeffrey P North; Courtney Onodera; Artur Zembowicz; Philip E LeBoit
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

6.  The many faces of blue nevus: a clinicopathologic study.

Authors:  Gerardo Ferrara; H Peter Soyer; Josep Malvehy; Domenico Piccolo; Susana Puig; Juan Sopena; Iris Zalaudek; Giuseppe Argenziano
Journal:  J Cutan Pathol       Date:  2007-07       Impact factor: 1.587

7.  Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.

Authors:  Sebastian Costa; Michelle Byrne; Daniel Pissaloux; Veronique Haddad; Sandrine Paindavoine; Luc Thomas; Francois Aubin; Thierry Lesimple; Florent Grange; Bertille Bonniaud; Laurent Mortier; Christine Mateus; Brigitte Dreno; Brigitte Balme; Beatrice Vergier; Arnaud de la Fouchardiere
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

8.  Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.

Authors:  Catherine D Van Raamsdonk; Vladimir Bezrookove; Gary Green; Jürgen Bauer; Lona Gaugler; Joan M O'Brien; Elizabeth M Simpson; Gregory S Barsh; Boris C Bastian
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

  8 in total
  1 in total

1.  Compound blue nevus: A misleading pigmented melanocytic tumor.

Authors:  Massara Baklouti; Khadija Sellami; Neila Elleuch; Mariem Rekik; Ines Saguem; Chahir Kamoun; Naourez Gouiaa; Hela Ben Messaoud; Fathi Karray; Mohamed Abdelmoula; Tahia Sellami; Hamida Turki
Journal:  Clin Case Rep       Date:  2022-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.